📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

337P Prediction of poor response to oxaliplatin by an RNA signature derived and validated in colorectal cancer clinical trials (2022)

First Author: Hassanieh S

Attributed to: MICA: Stratification in COloRectal cancer: from biology to Treatment prediction: S-CORT funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.annonc.2022.07.475

Publication URI: http://dx.doi.org/10.1016/j.annonc.2022.07.475

Type: Journal Article/Review

Parent Publication: Annals of Oncology